MBOT News and Press, Microbot Medical Inc. From 04/23/19

HINGHAM, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- As it continues to receive an overwhelming positive response from global jurisdictions, Microbot Medical Inc. (NASDAQ: MBOT) expands its IP portfolio as it receives a Notice of Allowance from the Canadian Intellectual Property Office for Pa...

HINGHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Further expanding its global IP portfolio, Microbot Medical Inc. (Nasdaq CM: MBOT) received an official communication from the European Patent Office regarding its intention to grant European Patent Application No. 13 746 563, which covers ...

HINGHAM, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT) is maintaining its milestone targets for 2019 following the recently announced decision of the New York State Supreme Court to rescind the Stock Purchase Agreement (“SPA”) Microbot enter...

Here's a brief look at the top 20 stocks of 2019 YTD through 2/25/19. I broke down the top performers between market capitalizations over $2 Billion and under $2 Billion. (Source: Finviz: see here ) Top Sector: Healthcare The commonality amongst the big winners is they come from the he...

MagneGas Applied Technology Solutions (NASDAQ: MNGA ) -46% . More news on: MagneGas Corporation, Cellect Biotechnology Ltd., Biocept, Inc., Stocks on the move, Read more ...

The European Patent Office has granted Microbot Medical (NASDAQ: MBOT ) a patent for Application No. 08738207, which covers ViRob technology platform. More news on: Microbot Medical Inc, Healthcare stocks news, Stocks on the move, Read more ...

HINGHAM, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Microbot Medical (NASDAQ: MBOT) announced today that it has validated the operational effectiveness of the Company’s Self-Cleaning Shunt (SCS TM ) in a recent independent in-vitro laboratory study. The Company also shared images of it...

HINGHAM, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT), received a notification from the European Patent Office that it will grant a patent for Application No. 08738207, which covers the Company’s ViRob™ technology platform. Including this lates...

HINGHAM, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT) announced today anticipated operational and product milestones, including pivotal pre-clinical study and FDA pre-submission milestones, for 2019. The progress and successful execution of key objectives...

Microbot Medical (NASDAQ: MBOT ) has filed a preliminary prospectus for an offering of up to ~6M Units, each consisting of one common share and one warrant to purchase one share of common at an assumed exercise price of $1.66. More news on: Microbot Medical Inc, Healthcare stocks news, S...